CGTN
Chinese President Xi Jinping arrived in east China's Anhui Province for an inspection tour on Tuesday.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200819005372/en/
Xi, also general secretary of the Communist Party of China Central Committee, visited the floodgate of the Wangjiaba Dam on the Huaihe River and other flood-hit areas in Funan County, Fuyang City. He also went to a "zhuangtai," a residential structure built on raised ground at a higher elevation that functions as a haven from river floods.
Since June, Anhui has been ravaged by floods and landslides caused by incessant heavy rains.
The president also met with local officials and residents and learned about flood prevention and disaster relief work and the progress of recovery efforts.
This is President Xi's latest inspection tour this year, following his visits to Yunnan Province , Beijing Municipality , Hubei Province , Zhejiang Province , Shaanxi Province , Shanxi Province , Ningxia Hui Autonomous Region and Jilin Province .
People-centered efforts
"I have always been concerned about the people in flood-stricken areas," Xi said while meeting locals, adding that he felt ease after seeing villagers had a place to live and had restarted production.
Severe rainstorms have hit many regions in China this summer, triggering flooding of rivers. According to the Ministry of Emergency Management (MEM), 54.8 million people in 27 provincial-level regions have been affected.
Chinese leaders have called for unrelenting efforts to ensure the safety of people's lives and property.
During a CPC leadership meeting on July 17, President Xi stressed putting people's lives and property first and taking more forceful measures to do well in flood control and relief work.
China has made all-out efforts in flood control and disaster relief with massive mobilization, evacuations and a top-level emergency response in several hard-hit provinces.
Through the nationwide joint efforts, the MEM said, the number of deaths and missing due to floods fell by 53.9 percent from with the national average of the past five years. The number of evacuated people increased by 36.7 percent, the ministry added.
Enhance capabilities to cope with natural disasters
Noting that China has fought against natural disasters for thousands of years, Xi on Tuesday also urged respect for nature, harmony between humans and nature and efforts to improve capabilities to cope with natural disasters.
"We should modernize our ability to prevent and combat natural disasters in our effort to build a modern socialist country in an all-round way," Xi added.
Hailed as the "most important floodgate on the Huaihe River," the floodgate of the Wangjiaba Dam sets a good example of China's flood preparation.
The floodgate, built in 1953 was opened for the 16th time on July 20 to store water, intercepting 375 million cubic meters of potential floodwater by July 23 when it was closed.
The CPC leadership meeting on July 17 also stressed that China needs to comprehensively enhance its disaster prevention capability and will include capacity building on disaster prevention in its 14th Five-Year Plan covering the period 2021-2025.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200819005372/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
